$143 Million

Applied Therapeutics, Inc.

Follow-on Offering

Bookrunner, January 2020

Applied Therapeutics, Inc.
Applied Therapeutics is a clinical stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.